Liangsong Lu, Yixuan Wang, Guolang Shen, Minghua Du
{"title":"Adaptive control of airway pressure during the expectoration process in a cough assist system.","authors":"Liangsong Lu, Yixuan Wang, Guolang Shen, Minghua Du","doi":"10.3389/fbioe.2024.1477886","DOIUrl":null,"url":null,"abstract":"<p><p>Existing Mechanical Insufflation-Exsufflation (MI-E) devices often overlook the impact of cough airflow pressure on mucus clearance, particularly lacking in control over airway pressure during the expiratory phase, which can lead to airway collapse and other types of airway damage. This study optimizes the design of cough assist system and explores the effectiveness of PID and adaptive control methods in regulating airway pressure. The adaptive control method compensates for hose pressure drop by online estimation of the ventilatory hose characteristics. It achieves precise tracking of target pressure and ensures the generation of peak flow rates effective for mucus clearance, even in the absence of known patient lung physiological states and unknown hose leakage parameters. Through a series of comparative experiments, this paper confirms the significant advantages of adaptive control in reducing oscillations and overshoot, capable of more stable and precise airway pressure adjustments. This improved control strategy not only enhances clinical safety but also significantly improves therapeutic outcomes and reduces the risk of complications. The findings indicate that the revamped cough assist system, employing an adaptive control strategy, can effectively prevent airway damage during assisted coughing, offering a safer and more effective sputum clearance solution for critically ill patients with expectoration disorders.</p>","PeriodicalId":12444,"journal":{"name":"Frontiers in Bioengineering and Biotechnology","volume":"12 ","pages":"1477886"},"PeriodicalIF":4.3000,"publicationDate":"2024-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11537939/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Bioengineering and Biotechnology","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3389/fbioe.2024.1477886","RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Existing Mechanical Insufflation-Exsufflation (MI-E) devices often overlook the impact of cough airflow pressure on mucus clearance, particularly lacking in control over airway pressure during the expiratory phase, which can lead to airway collapse and other types of airway damage. This study optimizes the design of cough assist system and explores the effectiveness of PID and adaptive control methods in regulating airway pressure. The adaptive control method compensates for hose pressure drop by online estimation of the ventilatory hose characteristics. It achieves precise tracking of target pressure and ensures the generation of peak flow rates effective for mucus clearance, even in the absence of known patient lung physiological states and unknown hose leakage parameters. Through a series of comparative experiments, this paper confirms the significant advantages of adaptive control in reducing oscillations and overshoot, capable of more stable and precise airway pressure adjustments. This improved control strategy not only enhances clinical safety but also significantly improves therapeutic outcomes and reduces the risk of complications. The findings indicate that the revamped cough assist system, employing an adaptive control strategy, can effectively prevent airway damage during assisted coughing, offering a safer and more effective sputum clearance solution for critically ill patients with expectoration disorders.
期刊介绍:
The translation of new discoveries in medicine to clinical routine has never been easy. During the second half of the last century, thanks to the progress in chemistry, biochemistry and pharmacology, we have seen the development and the application of a large number of drugs and devices aimed at the treatment of symptoms, blocking unwanted pathways and, in the case of infectious diseases, fighting the micro-organisms responsible. However, we are facing, today, a dramatic change in the therapeutic approach to pathologies and diseases. Indeed, the challenge of the present and the next decade is to fully restore the physiological status of the diseased organism and to completely regenerate tissue and organs when they are so seriously affected that treatments cannot be limited to the repression of symptoms or to the repair of damage. This is being made possible thanks to the major developments made in basic cell and molecular biology, including stem cell science, growth factor delivery, gene isolation and transfection, the advances in bioengineering and nanotechnology, including development of new biomaterials, biofabrication technologies and use of bioreactors, and the big improvements in diagnostic tools and imaging of cells, tissues and organs.
In today`s world, an enhancement of communication between multidisciplinary experts, together with the promotion of joint projects and close collaborations among scientists, engineers, industry people, regulatory agencies and physicians are absolute requirements for the success of any attempt to develop and clinically apply a new biological therapy or an innovative device involving the collective use of biomaterials, cells and/or bioactive molecules. “Frontiers in Bioengineering and Biotechnology” aspires to be a forum for all people involved in the process by bridging the gap too often existing between a discovery in the basic sciences and its clinical application.